ReviewHealth research policy and systems2025
Elements of healthcare delivery required to facilitate the clinical governance of hospital pharmacy services: a document review.
Review in Health research policy and systems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundClinical governance of hospital pharmacy services aims to ensure the delivery of pharmaceutical care that maximizes positive outcomes for patients. Good clinical governance incorporates service-related data to evaluate and improve care delivery. National-level clinical governance frameworks available in Australia provide limited information on auditable metrics to evaluate hospital pharmacy services. This study reviews healthcare governance documents to determine the goals and desirable elements of healthcare delivery and the information to measure to inform the clinical governance of hospital pharmacy services.
methodsA purposive online search was conducted to identify healthcare governance documents describing the clinical governance approach for general healthcare and hospital pharmacy services in Australia, New Zealand, England, Canada and the United States. Documents for general healthcare settings were reviewed to identify the goals and desirable elements of healthcare delivery. Pharmacy governance documents were then reviewed to contextualize the identified elements of care to hospital pharmacy services and to determine the information to measure to inform clinical governance.
resultsThe objective of delivering quality healthcare was included in all documents. Quality healthcare was described in the documents as healthcare that is patient-centred, safe, effective, integrated, timely, equitable, efficient and reliable. These factors were considered desirable elements of healthcare delivery that promote positive patient outcomes. The performance measures to evaluate and improve hospital pharmacy services delivery covered pharmacists' clinical activities, pharmaceutical care outcomes, stakeholder feedback and medication incidents and risks.
conclusionsMeasuring the extent to which the desirable elements of care are evident in the performance of clinical pharmacists' activities and the associated outcomes of care may provide useful information to facilitate the clinical governance of hospital pharmacy services.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.